Skip to search formSkip to main contentSkip to account menu

L 658310

Known as: L-658,310 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

BO 1236

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
L-658,310, a new injectable cephalosporin. I. In vitro antibacterial properties.
The in vitro antibacterial spectrum of L-658,310, a new semisynthetic cephalosporin, was compared with ceftazidime, aztreonam and… 
1989
1989
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Combinations of L-658,310 and an aminoglycoside or ciprofloxacin were tested against clinical isolates of Pseudomonas aeruginosa… 
1989
1989
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals.
The therapeutic activity of L-658,310 was demonstrated in experimental bacteremias in normal, diabetic and neutropenic mice… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)